{"id":"W2533355107","doi":"10.1182/blood.v122.21.3231.3231","title":"Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Induction Therapy For Newly Diagnosed Light Chain Amyloidosis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Maintenance therapy; Regimen; AL amyloidosis; Autologous stem-cell transplantation; Multiple myeloma; Population; Melphalan; Cyclophosphamide; Internal medicine; Surgery; Transplantation; Dexamethasone; Oncology; Gastroenterology; Chemotherapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002490275,0.0001295902,0.0002310484,0.000243068,0.0002697707,0.0002572751,0.0001520461,0.000158353,0.0006812746],"category_scores_gemma":[0.0003735671,0.00006870519,0.000167599,0.0001823911,0.0002153708,0.000123704,0.0001805616,0.0003354501,0.0001543464],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004833628,"about_ca_system_score_gemma":0.0003554983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008636523,"about_ca_topic_score_gemma":0.001495762,"domain_scores_codex":[0.9998602,0.0000397415,0.0000160939,0.00002926584,0.00001843,0.00003625434],"domain_scores_gemma":[0.9997591,0.00006434033,0.00004629842,0.00001541791,0.0000132823,0.0001016849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.04744218,0.005418798,0.6850549,0.0003640136,0.0002033278,0.01586583,0.0003871037,0.001949423,0.06752556,0.0003806112,0.001056734,0.1743516],"study_design_scores_gemma":[0.002509334,0.06103015,0.8749468,0.00006277327,0.0001561931,0.03218072,0.000160305,0.002051682,0.01827142,0.000118994,0.008492402,0.00001922413],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979416,0.0007747159,0.0001602794,0.00002568982,0.0000105781,0.00006824216,0.00006071737,0.000006325622,0.0009518505],"genre_scores_gemma":[0.9989531,0.0002972585,0.000204921,0.00005239645,0.00001931072,0.00002827226,0.0001218067,0.000001994714,0.0003209815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008636523,"threshold_uncertainty_score":0.003507078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009422756389824026,"score_gpt":0.2389838296463305,"score_spread":0.2295610732565065,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}